US pharmaceutical giant Pfizer has teamed up with China’s Fudan University to set up a Master’s degree programme in clinical data management and statistical programming.
The three-year course, which will be available to this September’s graduate intake, will focus on biostatistics, clinical sciences, clinical project management and pharmacovigilence.
Pfizer will offer students the chance to gain industry experience on various clinical projects. The firm also plans to provide $500,000 a year for the next three years to basic research conducted at the nearby Shanghai Institute of Biological Sciences (SIBS).
Professor Shaode Qin, Fudan University’s Chancellor, told Seeking Alpha that the ultimate aim of the partnership is to found a drug research and development centre at the university to teach the next generation of pharmaceutical scientists and engineers.